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INTRODUCTION
xperimental animal studies were used in addition to epi-
demiological studies to investigate the effects of expo-
sure, exposure rate, and other factors in predicting risks resulting
from human radon exposures. This review summarizes data on
lung cancer risk from radon experimental studies performed by
our group at CEA-COGEMA (France) with emphasis on the most
recent findings and analyses on the influence of dose-rate and
that of fatal versus incidental induced lung cancers.
Experimental animal studies of radon-induced lung cancer are
particularly helpful for understanding the carcinogenicity of human
exposures both in the home and in the workplace. Animals can be
exposed to a variety of agents under carefully controlled condi-
tions and then sacrificed for the study of developing lesions or
held for their lifespan for the development of tumors. Despite the
fact that significant cumulative exposures at typical residential
exposure rates of about 18 10-3 Jhm-3 (0.001 WLM per day) can-
not be tested in a short-lived species like the rat, the rat model is
valuable for confirming the conclusions acquired from human
data particularly in regard to the exposure-rate effect. Radon
health effect data, developed primarily in adult male rats were pro-
vided by the Pacific Northwest National Laboratory (PNNL) (1),
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This review summarizes data on lung cancer risk from radon experimental studies per-
formed by our group in France with emphasis on the most recent findings and analyses
on the influence of dose-rate and that of fatal versus incidental tumors. A dose-effect rela-
tionship was established in rats, which was very similar for medium and high cumulative
exposures, to that observed in uranium miners. At low cumulative exposures in the range
of 0.18 Jhm-3 (50 WLM) to 0.36 Jhm-3 (100 WLM), the proportion of fatal lung cancer is
about 80% that of total lung cancers. In contrast, at cumulative exposures of 0.72 Jhm-3
(200 WLM) and higher, the proportion of fatal lung cancer is about half that of total lung
cancers. The parameters that influence fatal lung cancer risk are cumulative exposure,
potential alpha energy concentration (PAEC), exposure rate, and protraction of exposure.
At high cumulative exposures up to 10.8 Jhm-3 (3,000 WLM), an inverse dose-rate effect
similar to that observed in uranium miners was also found in rats. The inverse exposure-
rate effect was observed mainly at the highest exposure-rates. In contrast, our recent
results indicate that at relatively low cumulative exposures of 0.36 Jhm-3 (100 WLM),
comparable to lifetime exposures in high-radon houses or current underground mining
exposures, the risk of lung cancer in rats decreases with decreasing PAEC, i.e., exposure
rate. These data suggest that the induction of lung cancer results from a complex inter-
play between cumulative exposure and exposure rate, with an optimal combination of
these two parameters that results in a maximum risk of lung cancer induction. They sup-
port the hypothesis that, at low doses, the risk of lung cancer is governed by the rate at
which the dose is delivered, and not by the total cumulative dose alone. These data are
also consistent with those of underground uranium miners showing an inverse dose-rate
effect at high cumulative exposures, but an attenuation of this effect at cumulative expo-
sures lower than 0.18 Jhm-3 (50 WLM). They support both an inverse dose-rate effect at
high cumulative exposures, as well as its attenuation or disappearance at low cumulative
exposures.
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Eformerly PNL, in USA, and in Europe by AEA-Technology in UK
(2), and CEA-COGEMA in France (3). Under the Fourth
Commission of the European Community Research and
Development Framework Research Programme (4th CEC FP), a
new series of experiments were carried out to investigate specif-
ically the influence of exposure rate on lung cancer induction in
rats. The animal experiments were conducted concomitantly at
CEA (France) and AEA-Technology (Harwell, UK). They were per-
formed at relatively low cumulative exposure comparable to life-
time exposures in high-radon houses or current underground
mining exposures of around 0.36 Jhm-3 (100 WLM). Where pos-
sible, the experimental conditions used at the two laboratories
were similar, for example both groups used rats of the same
strain, sex and age (male Sprague-Dawley rats, 3-months old at
the beginning of exposure). In addition, the metrology of the radon
exposure atmospheres and the reporting of pathology were stan-
dardized between the two groups (4). The principal differences
between the exposure conditions were that exposures were con-
ducted during the working day at CEA, without introduction of car-
rier aerosol, whereas they were conducted continuously at
Harwell (24 hours per day), using Carnauba wax as a carrier
aerosol. The results of the French experiments have been pub-
lished recently (5). A paper reporting the results from AEA-
Technology is in preparation. A joint analysis of both AEA-
Technology and CEA-COGEMA rat data is also expected soon.
FATAL AND INCIDENTAL LUNG TUMORS
Different analyses of various animal data sets have already been
performed and the importance of categorization of lung tumors as
fatal or incidental to the death of the animals was extensively dis-
cussed. The experiments conducted at CEA and AEAT were lifes-
pan studies in which, after exposure, rats were kept and regular-
ly observed until death and killed when moribund. Rats do not,
generally, die from lung cancer. Thus, so-called fatal tumors that
are thought to grow faster and to cause more serious health
effects than incidental tumors were determined on the basis of
histopathological criteria. Also close similarities exist between
fatal tumors in rats and human lung cancers. An analysis of fatal
and incidental lung tumours was performed in rats from the CEA-
COGEMA data sets for which sufficiently detailed information was
available and a full analysis of fatal tumors has been performed.
In this analysis, a tumor was considered as fatal if one of the fol-
lowing criteria was satisfied (6): presence of a single metastasis
or multiple metastases, tumor size depending on the structure
affected, but generally larger than 15 mm in diameter, presence
of marked necrosis affecting more than 50% of the lesion, exten-
sive invasion into pleura, bronchi and/or blood vessels. 
These assessment criteria have been found to be comparable
with that used for PNNL rodent and dog data. 
Table 1 summarizes the characteristics of exposure in the differ-
ent experimental groups of rats exposed to radon and its proge-
ny. Table 2 summarizes the number and proportion of total lung
cancers as well as that of fatal lung cancers, as classified by the
system defined above. In this analysis, control rats from both
AEA-Technology and CEA-COGEMA were pooled together (same
strain, sex, age at exposure...). In the CEA-COGEMA studies, five
cases of lung cancers were observed in a series of historical con-
trols, but none of them could be considered as fatal. In a series of
240 control rats, contemporary of the last dose-rate effect study
(5), no lung tumor was observed. So, there was no fatal lung can-
cer among the 1025 control rats from our data sets. In contrast,
one case of fatal lung cancer was observed among the AEA-
Technology 496 control rats. Thus, it was agreed between both
institutes to pool their control rat data sets, allowing us to estab-
lish the background incidence of fatal lung cancers in controls at
1 in 1521 rats (0.07 %).
DOSE-EFFECT RELATIONSHIP
It has been demonstrated that exposure to radon and its progeny
induces lung cancer in rats (7). An excess risk of lung cancers was
observed in rats at cumulative exposure as low as 0.09 Jhm-3 (25
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Table 2. Number and proportion of total and fatal lung cancers in the different
experimental groups of rats exposed to radon and its progeny
Table 1. Characteristics of exposures in the different experimental groups of rats
exposed to radon and its progenyWLM) performed at relatively high potential alpha energy concen-
tration (PAEC) of about 2.1 mJm-3 (100 WL) (8). A dose-effect
relationship was established showing that the incidence of lung
cancers in rats exposed to radon/radon progeny increased with
cumulative exposure (3). Figure 1 shows the incidence of total
and fatal lung cancers in rats exposed at cumulative exposures up
to 21.6 Jhm-3 (6,000 WLM). The proportion of both total and fatal
lung cancers in rats increased for cumulative exposures ranging
from 0.09 Jhm-3 (25 WLM) up to 10.8 Jhm-3 (3,000 WLM), and
decreased thereafter. However, in rats that received at cumulative
exposure of 0.72 Jhm-3 (200 WLM) or higher, the proportion of
fatal lung cancer is about half that of total lung cancers.  
For medium and high cumulative exposures, the pattern of this
dose-effect relationship was very similar to that observed in
underground uranium miners in whom a significant excess of
lung cancers was observed for cumulative exposure ranging from
about 0.36 Jhm-3 (100 WLM) to 1.44 Jhm-3 (400 WLM) and
above (9). However, excess respiratory tract tumors were pro-
duced in rats at exposures considerably lower than 0.36 Jhm-3
(100 WLM), even at cumulative exposures (although not expo-
sure rates) comparable to typical lifespan exposures in homes at
about 0.09 Jhm-3 (25 WLM).
A cumulative exposure of 0.09 Jhm-3 (25 WLM), at a high expo-
sure rate of 2.08 mJm-3 (100 WL), resulted in a three to four-fold
increased lung cancer frequency in male Sprague-Dawley rats as
compared to unexposed control rats (10). At cumulative expo-
sures of 0.18 Jhm-3 (50 WLM) and 0.36 Jhm-3 (100 WLM), the
proportion of fatal lung cancer is about 80% that of total lung can-
cers. In the PNNL experiments, more than 70% of squamous cell
(epidermoid) carcinomas, but only 20% of the adenocarcinomas
were classified as fatal. Similar findings were also observed in our
experiments but the situation was somewhat different in the dif-
ferent experimental groups according to the cumulative exposures
and the PAEC at which the animals were exposed. In rats exposed
at cumulative exposures of about 0.36 Jhm-3 (100 WLM) and
lower, the proportion of fatal squamous cell carcinomas (57%)
and that of fatal adenocarcinomas (59%) was quite similar, and 3
on 4 of adenosquamous carcinomas (75%) should be considered
as fatal. 
Figure 2 shows the relative incidence of squamous cell carcino-
mas and adenocarcinomas in rats exposed at 0.36 Jhm-3 (100
WLM) and lower, according as a function of PAEC. Roughly, the
frequency of fatal squamous cell carcinomas that are related to
the severity of the aggression of the carcinogenic agent,
increased with increasing PAEC.
In rats that received cumulative exposures of about 0.36 Jhm-3
(100 WLM) or lower, the first observed death was due to a bron-
choalveolar adenocarcinoma that occurred at the age of 589 days
in a rat exposed at 0.18 Jhm-3 (50 WLM) and high PAEC of 2.08
mJm-3 (100 WL). However, except for one rat that died from a
squamous cell carcinoma very late (1,019 days of age), the
majority of squamous cell carcinoma deaths occurred very early
in the lifetime of rats. The first two deaths from squamous cell
carcinomas occurred at the age of 589 and 596 days in groups
Rn50HDr and RnD1, respectively, and almost all of these deaths
occurred before 900 days of age. In contrast, adenocarcinoma
deaths occurred later, between 800 and 1100 days of age, and
were evenly distributed over the last 300 days of rat lifetime.
Figure 3 shows the relative incidence of squamous cell carcino-
mas and adenocarcinomas in rats exposed at 0.7 Jhm-3 (200
WLM) and higher, which were exposed at a similar PAEC of about
25 mJm-3 (1,200 WL). Roughly, the frequency of fatal squamous
cell carcinomas, increased with cumulative exposures up to 10.8
Jhm-3 (3,000 WLM) and decreased thereafter.
In contrast, the frequency of fatal adenocarcinomas, increased
with cumulative exposures only up to 1.8 Jhm-3 (500 WLM) and
decreased thereafter. In rats exposed at cumulative exposures of
about 0.72 Jhm-3 (200 WLM) and higher, the proportion of fatal
Lung cancer risk in radon-exposed rats
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Figure 1. Compared incidence of total (TLC) and fatal (FLC) lung cancers in rats
exposed to radon and its progeny at various cumulative exposures (0.25 WLM is
the estimated cumulative exposure of controls)
Figure 2. Relative proportion of fatal and non fatal lung cancers according to their
histological types in rats exposed at 100 WLM and lower and various PAEC
(FSCC: fatal squamous cell carcinoma; NFSCC: non fatal squamous cell carcino-
ma; FADK: fatal adenocarcinoma; NFADK: non fatal adenocarcinoma)squamous cell carcinomas (66%) and that of fatal adenocarcino-
mas (30%) was quite similar to that observed in PNNL rats. On
the other hand, 4 of the 6 observed adenosquamous carcinomas
(66%) were considered fatal. It should be noted that PNNL used
Wistar rats.
In rats exposed at cumulative exposures higher than 0.72 Jhm-3
(200 WLM), the first lung cancers deaths were of the squamous
cell type and occurred very early, at 365 days of age, in rats
exposed at 1.8 Jhm-3 (500 WLM) and a high PAEC of about 25
mJ m-3 (1200 WL). About two-thirds of squamous cell carcino-
mas deaths occurred before 600 days of age. In contrast, adeno-
carcinomas deaths occurred later in life and were evenly distrib-
uted between 420 and 930 days in the rat lifetime. About 80 % of
the adenocarcinomas observed in rats exposed at 0.72 Jhm-3
(200 WLM) and higher were not fatal. These tumors were gener-
ally small in size, poorly invasive and they did not metastasize.
They occurred very late in the lifetime of the animals or, in other
words, they allow the rats to live with their lung cancer. This could
explain why rats bearing lung tumors, whether fatal or not, live
generally longer than those without lung tumors (11). These
observations also suggest that the kinetics of development of
incidental tumors and especially that of adenocarcinomas, includ-
ing parameters like cell growth, doubling time, etc., would be dif-
ferent from that of squamous cell carcinoma and adenosqua-
mous carcinomas and involve different cellular and molecular
mechanisms.
LIFETIME EXCESS ABSOLUTE RISK
Figure 4 shows the lifetime excess absolute risk (LEAR) of lung
fatal cancers in rats exposed to radon and its progeny at various
cumulative exposures and PAEC. The lifetime LEAR increases
with cumulative exposures up to 10.8 Jhm-3 (3,000 WLM), and
decreased thereafter. The higher LEAR values are observed in
groups exposed at high cumulative exposures of 0.36 Jhm-3 (100
WLM) and higher and high PAEC of 3.91 mJ m-3 and 25 mJm-3
(188 WL and 1200 WL), respectively. In contrast the lowest LEAR
values († 5%) are observed in rats exposed at cumulative expo-
sures lower than 0.36 Jhm-3 (100 WLM) and PAEC lower than
2.08 mJm-3 (100 WL).
Figure 5 shows the combined influence of cumulative exposure
expressed in terms of WLM and of PAEC, expressed in terms of
WL, on the excess absolute risk per unit exposure (EAR per WLM)
of fatal lung cancers in CEA rats. For cumulative exposures high-
er than 100 WLM, and PAEC higher than 150 WL, the risk of fatal
lung cancer decreases with increasing cumulative exposure and
increasing PAEC. In contrast, for cumulative exposures lower
than 100 WLM, the risk of lung cancer decreases with decreas-
ing PAEC. The risk of lung tumor induction in rats appears to be
maximal for cumulative exposures ranging from 50 WLM up to
100 WLM, and PAEC ranging from 58 WL up to 188 WL.
In the same way, Figure 6 shows the combined influence of
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Figure 3. Relative proportion of fatal and non-fatal lung cancers according to their
histological types in rats exposed at cumulative exposures of 200 WLM and high-
er and similar PAEC of 1,200 WL (FSCC: fatal squamous cell carcinoma; NFSCC:
non fatal squamous cell carcinoma; FADK: fatal adenocarcinoma; NFADK: non
fatal adenocarcinoma)
Figure 4. Lifetime excess absolute risk (x 10-4) of fatal lung cancer in rats
exposed at various cumulative exposures (WLM log transformed) and potential
alpha energy concentrations (PAEC, expressed in WL)
Figure 5. Schematic representation of the lifetime excess absolute risk (x 10-4)
per WLM of fatal lung cancer in rats exposed to radon and its progeny at various
cumulative exposures (WLM) and PAEC (WL). Note that x (WLM) and y (WL) axes
are categoricalcumulative exposure expressed in terms of WLM and of exposure
rate, expressed in terms of WLM per day, on the excess absolute
risk per unit exposure (EAR per WLM) of fatal lung cancers in CEA
rats. For cumulative exposures higher than 100 WLM, and PAEC
higher than 150 WL, the risk of fatal lung cancer decreases with
increasing cumulative exposure and increasing exposure rates. In
contrast, for cumulative exposures lower than 100 WLM, the risk
of lung cancer decreases with decreasing exposure rates.
Moreover, the risk of lung tumor induction in rats appears to be
maximal for cumulative exposures ranging from 50 WLM up to
107 WLM, and exposure rates ranging from 1.1 WLM per day up
to 3.5 WLM per day.
DISCUSSION 
In the present study, an important effort has been made to dis-
criminate incidental from fatal tumors and a full analysis of fatal
tumors has been performed. One advantage of such animal data
over human data is that they provide rigorous and detailed infor-
mation and risk estimates over the whole life of the animals. The
analysis of the data showed that the parameters that influence
fatal lung cancer risk are cumulative exposure, PAEC, exposure-
rate, and protraction of exposure. The highest fatal lung cancer
risk is observed in rats exposed at about 0.36 Jhm-3 (100 WLM),
at high PAEC in the range of 3 to 4 mJm-3 (150-200 WL), and/or
high exposure-rate from about 3.5 to 5 WLM/day, delivered over
a short period (30 days). At cumulative exposures lower than
0.18 Jhm-3 (50 WLM), the risk decreases with decreasing PAEC,
decreasing exposure rates and increased protraction of exposure.
At cumulative exposures higher than 0.72 Jhm-3 (200 WLM), the
highest risk occurred in rats exposed at 1.8 Jhm-3 (500 WLM),
high PAEC of about 25 mJm-3 (1,200 WL), and/or high exposure-
rate of about 10 WLM/day, delivered for a short period of time of
about 50 days. At very high cumulative exposures of about 1.8
Jhm-3 (500 WLM) and higher, the risk decreases with increased
cumulative exposure, decreasing exposure rates and increased
protraction of exposure. The highest proportion of squamous cell
carcinomas that is related with the severity of the aggression of
the carcinogenic agent and thus the severity of the health detri-
ment, was observed in rats exposed at high PAEC and decreased
with decreasing PAEC. The larger and most invasive tumors were
also observed in rats exposed at high PAEC and the size and inva-
siveness of tumors decreased with decreasing PAEC and/or
increasing protraction of exposure.
This analysis confirms previous results, showing that at high
cumulative exposures, the risk of lung cancers in rats increases
with decreasing PAEC (5). This effect, which is also observed in
underground miners, is called the inverse dose-rate effect or pro-
traction enhancement effect. In contrast, the present results indi-
cate that at relatively low cumulative exposures of about 100
WLM, comparable to lifetime exposures in high-radon houses or
current underground mining exposures, the risk of lung cancer in
rats decreases with PAEC, i.e., exposure-rate, confirming the
results obtained at lower cumulative exposures (10). The inverse
exposure-rate effect was observed mainly at the highest expo-
sure-rates. The pattern of the diagrams showing the influence of
cumulative exposure expressed in terms of WLM and of PAEC,
expressed in terms of WL, or exposure rate expressed in terms of
WLM/day, on the excess absolute risk per unit exposure (EAR per
WLM) of fatal lung cancers in rats is very similar to that obtained
when considering the influence of these parameters on the
excess relative risk (ERR) per WLM of total lung cancers (11).
The use of the excess absolute risk allows us to compare the
number of additional fatal lung cancer cases in the different
groups of rats by taking into account the absolute value of back-
ground incidence in controls. In the present analysis, the lifetime
excess relative risks (LERR) per WLM ranged between 1 and 6%,
and were higher than that estimated in human exposed popula-
tions, mainly underground miners. In contrast the LEAR of fatal
lung cancer per WLM in our animal experiments, ranged between
0.06 and 5 10-4, and were comparable with that estimated in min-
ers studies.
These data suggest that the induction of fatal lung cancer is the
result of a complex interplay between cumulative exposure and
exposure rate, with an optimum combination of these two para-
meters that results in a maximum risk of tumor induction. They
support the hypothesis that, at low doses, the risk of lung cancer
is governed by the rate at which the dose is delivered, and not by
the total cumulative dose alone. These data are also consistent
with that from underground uranium miners showing an inverse
dose-rate effect at high cumulative exposures, but an attenuation
of this effect at cumulative exposures lower than 50 WLM (12). In
Lung cancer risk in radon-exposed rats
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Figure 6. Schematic representation of the lifetime excess absolute risk (x 10
-4)
per WLM of fatal lung cancer in rats exposed to radon and its progeny various
cumulative exposures (WLM) and exposure rates (WLM/day). Note that x (WLM)
and y (WLM/day) axes are categoricalthat way, no dose-rate effect was observed in the recent joint
analysis of Czech and French uranium miners exposed to low
cumulative exposures (mean cumulative exposures of 36.5 WLM
and 57.3 WLM, respectively) (13). Even if they cannot provide a
direct estimation of the risk associated to radon exposure among
human populations, the risk estimates obtained from animal data
are useful because of their similarities with those obtained in
underground miners. Our experimental data support both an
inverse dose-rate effect at high cumulative exposures, as well as
its attenuation or disappearance at low cumulative exposures.
Quantitative modeling of data from animal studies provided risk
coefficients that can be compared with similarly derived coeffi-
cients from epidemiological data. Different applications of two-
step mutation models were tested in two largest data sets of rats
exposed from both PNNL in USA and CEA-COGEMA in France, as
well as in various miner studies (14-16). During the Fifth CEC FP,
a risk analysis of animal data was performed in connection with
AEA-Technology and different partners involved in statistical
modeling (13). This allowed comparison of the different data sets
of recent animal data from partners of CEA and AEA-Technology
on exposure rate with those of previously analyzed data, to scale
biological parameters and risk between rats and humans and to
achieve statistical modeling of the underlying mechanisms.
Statistical modeling of animal data provided qualitative agreement
with miners’ solutions. Nevertheless, to go further in the compar-
ison of risk estimates between human and animal data, addition-
al effort is needed, especially for adapting the effect of age and
the differences in organ dose (17).
Footnote
Radiological protection units. A working level (WL) is defined as any combination
of the short-lived radon progeny in one liter of air, under ambient temperature and
pressure, that results in the ultimate emission of 1.3 105 MeV of alpha particle
energy. One WL corresponds approximately to the potential alpha energy con-
centration (PAEC) of short-lived radon decay products in air that are in equilibri-
um with a radon gas concentration of 3.7 103 Bq m-3 of air (100 pCi l-1 of air). 
The potential alpha energy exposure of miners is often expressed as working level
months (WLM). This unit is generally used to estimate exposure to radon decay
products in epidemiological studies of miners and for establishing radiation lim-
its in mines. One WLM corresponds to exposure to a concentration of 1 WL for a
reference period of 170 hours: 1 WLM = 170 WLh = 3.5 mJ h m-3
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